| CPC A61K 9/1647 (2013.01) [A61K 9/1682 (2013.01); A61K 31/135 (2013.01)] | 6 Claims |
|
1. A microsphere formulation, comprising:
polymer microspheres, each polymer microsphere comprising:
esketamine in a concentration of about 10 wt/wt % to about 30 wt/wt %; and
a biodegradable poly(lactide) polymer in a concentration of about 70 wt/wt % to about 90 wt/wt %, wherein the biodegradable poly(lactide) polymer has an inherent viscosity from about 0.6 dL/g to about 0.7 dL/g;
wherein the polymer microspheres have a particle size greater than 60 μm (D50);
wherein the polymer microspheres are characterized in that each of the polymer microspheres comprises an internal polymer phase, a plurality of internal macrovoids dispersed within the internal polymer phase, and an outer surface substantially free of voids; and
wherein the polymer microspheres are prepared by a method that does not include the use of a porogen, the method comprising:
(i) contacting the esketamine with the biodegradable poly(lactide) polymer in the presence of a solvent to form an organic component;
(ii) emulsifying an inner aqueous component comprising water with the organic component to form a primary emulsion;
(iii) emulsifying the primary emulsion with a continuous phase comprising water to form a secondary emulsion;
(iv) removing the solvent from the secondary emulsion to form the polymer microspheres; and
(v) subjecting the polymer microspheres to dehydration.
|